Tuesday 9 October 2012

Pfizer to pay $164 million in investor lawsuit over Celebrex

(Reuters) - Pfizer Inc has agreed to pay $164 million to settle a shareholder class action accusing the drug maker of misrepresenting the clinical trial results for Celebrex.

via Reuters: Health News Read More Here..

No comments:

Post a Comment